Halozyme Therapeutics Inc (HALO) — Net Asset Quality Index
Halozyme Therapeutics Inc (HALO) has a Net Asset Quality Index of 22.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $2.22 Billion minus total liabilities of $1.72 Billion yields net assets of $503.92 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Halozyme Therapeutics Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Halozyme Therapeutics Inc Net Asset Quality Index Over Time (2001–2024)
This chart shows how Halozyme Therapeutics Inc's Net Asset Quality Index has evolved across 24 annual periods from 2001 to 2024. As of September 2025, the index stands at 22.7%, representing net assets of $503.92 Million against total assets of $2.22 Billion USD. Explore Halozyme Therapeutics Inc operating cash flow efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Halozyme Therapeutics Inc (2001–2024)
The table below presents the year-by-year Net Asset Quality Index for Halozyme Therapeutics Inc from 2001 to 2024, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Halozyme Therapeutics Inc market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 17.6% | $363.82 Million | $2.06 Billion | $1.70 Billion | ▲ +12.8 pp |
| 2023 | 4.8% | $83.81 Million | $1.73 Billion | $1.65 Billion | ▼ -4.4 pp |
| 2022 | 9.2% | $169.80 Million | $1.84 Billion | $1.67 Billion | ▼ -8.6 pp |
| 2021 | 17.8% | $196.95 Million | $1.10 Billion | $907.48 Million | ▼ -8.2 pp |
| 2020 | 26.0% | $151.05 Million | $579.92 Million | $428.88 Million | ▲ +9.8 pp |
| 2019 | 16.2% | $91.77 Million | $565.87 Million | $474.11 Million | ▼ -40.3 pp |
| 2018 | 56.5% | $248.89 Million | $440.25 Million | $191.36 Million | ▲ +16.5 pp |
| 2017 | 40.1% | $208.37 Million | $519.95 Million | $311.58 Million | ▲ +52.5 pp |
| 2016 | -12.4% | $-32.48 Million | $261.51 Million | $294.00 Million | ▼ -36.1 pp |
| 2015 | 23.7% | $43.00 Million | $181.79 Million | $138.79 Million | ▼ -1.3 pp |
| 2014 | 24.9% | $41.35 Million | $165.98 Million | $124.62 Million | ▲ +44.6 pp |
| 2013 | -19.6% | $-19.99 Million | $101.79 Million | $121.78 Million | ▼ -55.9 pp |
| 2012 | 36.3% | $48.85 Million | $134.73 Million | $85.87 Million | ▲ +19.7 pp |
| 2011 | 16.6% | $10.90 Million | $65.76 Million | $54.86 Million | ▼ -5.7 pp |
| 2010 | 22.3% | $20.35 Million | $91.35 Million | $70.99 Million | ▲ +13.3 pp |
| 2009 | 8.9% | $6.90 Million | $77.15 Million | $70.25 Million | ▼ -11.1 pp |
| 2008 | 20.1% | $15.38 Million | $76.56 Million | $61.18 Million | ▼ -35.7 pp |
| 2007 | 55.8% | $57.77 Million | $103.46 Million | $45.69 Million | ▲ +5.8 pp |
| 2006 | 50.1% | $23.08 Million | $46.09 Million | $23.01 Million | ▼ -38.7 pp |
| 2005 | 88.8% | $18.21 Million | $20.51 Million | $2.30 Million | ▼ -1.6 pp |
| 2004 | 90.4% | $14.82 Million | $16.40 Million | $1.58 Million | ▲ +69.2 pp |
| 2003 | 21.2% | $10.06K | $47.52K | $37.45K | ▼ -68.1 pp |
| 2002 | 89.3% | $86.81K | $97.25K | $10.43K | ▲ +1.9 pp |
| 2001 | 87.4% | $22.84K | $26.13K | $3.29K | — |